Baxter in Belgium

Intravenous products: PharmPro report “Baxter established roots In Belgium in the mid-1950s, when it became the first company in Belgium to commercially manufacture sterile intravenous solutions. Today, Baxter remains a leader in Belgium in providing products that save and sustain lives. Belgium also continues to be a strategic location for Baxter manufacturing and research and development (R&D) in Europe.

In June 2010, Baxter opened a new R&D center in Belgium, in the town of Braine-l’Alleud. Called “Parc de l’Alliance,” or Alliance Park, the facility also will serve as the company’s new Belgium headquarters. The 154,000-square-foot facility brings together employees from Baxter’s previous Belgium R&D facility in Nivelles and the company’s former Belgium headquarters in Brussels.

“Research and development is one of Baxter’s most important strategic priorities,” says Bernhard Kutscher, vice president of R&D for Baxter in Europe. “With the company’s emphasis on innovation, the new building will provide more space, new laboratories, and advanced scientific and technical capabilities to support our product development initiatives going forward.”

The R&D staff in Alliance Park consists of scientists, engineers and technicians involved in a range of R&D activities for Baxter’s three businesses – BioScience, Medication Delivery and Renal. Areas of expertise include biochemistry, cellular and molecular biology, histology, pharmaceutical sciences, materials technology, analytical chemistry, electronic microscopy and various engineering disciplines.”

Click here for the full story.

Other stories